Everolimus in combination with exemestane in the treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer who are refractory to letrozole or anastrozole: Preliminary results of the BOLERO-2 trial. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Baselga, J
  • Campone, M
  • Piccart-Gebhart, MJ
  • Burris, HA
  • Rugo, HS
  • Noguchi, S
  • Gnant, M
  • Pritchard, Kathleen
  • Lebrun, F
  • Beck, JT
  • Ito, Y
  • Yardley, DA
  • Deleu, I
  • Perez, A
  • Bachelot, TD
  • Vittori, L
  • Mukhopadhyay, P
  • Weber, D
  • Sahmoud, T
  • Hortobagyi, GN

publication date

  • May 20, 2011